Future Financial Wealth Managment LLC Sells 500 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Future Financial Wealth Managment LLC lowered its holdings in Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 6.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,703 shares of the real estate investment trust’s stock after selling 500 shares during the period. Future Financial Wealth Managment LLC’s holdings in Omega Healthcare Investors were worth $273,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of OHI. Daiwa Securities Group Inc. boosted its holdings in Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock valued at $32,384,000 after purchasing an additional 861,907 shares during the period. Marshall Wace LLP bought a new stake in Omega Healthcare Investors in the 2nd quarter valued at about $20,962,000. BROOKFIELD Corp ON bought a new stake in Omega Healthcare Investors in the 1st quarter valued at about $16,446,000. Vanguard Group Inc. lifted its holdings in shares of Omega Healthcare Investors by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 35,214,682 shares of the real estate investment trust’s stock worth $1,079,682,000 after acquiring an additional 346,811 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after acquiring an additional 272,299 shares during the period. Institutional investors own 65.25% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on OHI. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Scotiabank upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets upped their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday. Finally, Truist Financial upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $37.00.

View Our Latest Analysis on OHI

Omega Healthcare Investors Trading Up 0.0 %

OHI opened at $39.51 on Wednesday. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $41.53. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a fifty day moving average of $39.16 and a 200-day moving average of $34.72. The stock has a market cap of $9.76 billion, a PE ratio of 35.59, a price-to-earnings-growth ratio of 1.29 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The company had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s revenue was up 17.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.74 earnings per share. On average, sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.78%. The ex-dividend date of this dividend was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio is presently 241.44%.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

About Omega Healthcare Investors

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Further Reading

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.